Cohort Studymoderate evidence
GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder.
The Journal of clinical psychiatry·July 15, 2026·PMID 42474323
Why it mattersOpioid use disorder remains a leading cause of overdose death, and effective pharmacotherapies are limited. These findings add to emerging evidence that GLP-1 receptor agonists may reduce overdose risk in patients with OUD, potentially offering a dual-benefit option for those with comorbid type 2 diabetes.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled